This website uses cookies
Read our Privacy policy and Terms of use for more information.
Eli Lilly just became pharma's first trillion-dollar company. So naturally, its CEO is behaving like a man bracing for the worst. Here's why the smartest move at the top might be planning for the fall.
Oct 16, 2026
•
5 min read
